Literature DB >> 26047984

Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.

Christine E Briggs1, Yulei Wang2, Benjamin Kong2, Tsung-Ung W Woo3, Lakshmanan K Iyer4, Kai C Sonntag5.   

Abstract

The degeneration of substantia nigra (SN) dopamine (DA) neurons in sporadic Parkinson׳s disease (PD) is characterized by disturbed gene expression networks. Micro(mi)RNAs are post-transcriptional regulators of gene expression and we recently provided evidence that these molecules may play a functional role in the pathogenesis of PD. Here, we document a comprehensive analysis of miRNAs in SN DA neurons and PD, including sex differences. Our data show that miRNAs are dysregulated in disease-affected neurons and differentially expressed between male and female samples with a trend of more up-regulated miRNAs in males and more down-regulated miRNAs in females. Unbiased Ingenuity Pathway Analysis (IPA) revealed a network of miRNA/target-gene associations that is consistent with dysfunctional gene and signaling pathways in PD pathology. Our study provides evidence for a general association of miRNAs with the cellular function and identity of SN DA neurons, and with deregulated gene expression networks and signaling pathways related to PD pathogenesis that may be sex-specific.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dopamine neurons; IPA; Laser capture microdissection; Parkinson׳s disease; miRNAs

Mesh:

Substances:

Year:  2015        PMID: 26047984      PMCID: PMC4522231          DOI: 10.1016/j.brainres.2015.05.021

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  98 in total

1.  Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5.

Authors:  Yinghua Zhu; Fengyan Yu; Yu Jiao; Juan Feng; Wei Tang; Herui Yao; Chang Gong; Jianing Chen; Fengxi Su; Yan Zhang; Erwei Song
Journal:  Clin Cancer Res       Date:  2011-09-27       Impact factor: 12.531

2.  L1 neural cell adhesion molecule is a survival factor for fetal dopaminergic neurons.

Authors:  P Hulley; M Schachner; H Lübbert
Journal:  J Neurosci Res       Date:  1998-07-15       Impact factor: 4.164

3.  Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells.

Authors:  Yuncheng Wu; Xinqun Li; Wenjie Xie; Joseph Jankovic; Weidong Le; Tianhong Pan
Journal:  Neurochem Int       Date:  2010-05-28       Impact factor: 3.921

Review 4.  Synaptic retinoic acid signaling and homeostatic synaptic plasticity.

Authors:  Lu Chen; Anthony G Lau; Federica Sarti
Journal:  Neuropharmacology       Date:  2012-12-25       Impact factor: 5.250

5.  MicroRNAs in metabolism and metabolic diseases.

Authors:  V Rottiers; S H Najafi-Shoushtari; F Kristo; S Gurumurthy; L Zhong; Y Li; D E Cohen; R E Gerszten; N Bardeesy; R Mostoslavsky; A M Näär
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-12-12

Review 6.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

Review 7.  MicroRNAs in the regulation of TLR and RIG-I pathways.

Authors:  Yingke Li; Xueyin Shi
Journal:  Cell Mol Immunol       Date:  2012-12-24       Impact factor: 11.530

8.  In vitro and in vivo enhanced generation of human A9 dopamine neurons from neural stem cells by Bcl-XL.

Authors:  Elise T Courtois; Claudia G Castillo; Emma G Seiz; Milagros Ramos; Carlos Bueno; Isabel Liste; Alberto Martínez-Serrano
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

Review 9.  RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.

Authors:  Sabrina M Heman-Ackah; Martina Hallegger; Mahendra S Rao; Matthew J A Wood
Journal:  Front Mol Neurosci       Date:  2013-11-20       Impact factor: 5.639

10.  Vav3-deficient mice exhibit a transient delay in cerebellar development.

Authors:  Celia Quevedo; Vincent Sauzeau; Mauricio Menacho-Márquez; Antonio Castro-Castro; Xosé R Bustelo
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

View more
  29 in total

Review 1.  Nucleic Acid-Based Therapeutics for Parkinson's Disease.

Authors:  Masayuki Nakamori; Eunsung Junn; Hideki Mochizuki; M Maral Mouradian
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 2.  MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.

Authors:  Mohammad Rafi Khezri; Keyvan Yousefi; Naime Majidi Zolbanin; Morteza Ghasemnejad-Berenji
Journal:  Mol Neurobiol       Date:  2022-01-09       Impact factor: 5.590

Review 3.  Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.

Authors:  Julia Doroszkiewicz; Magdalena Groblewska; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 4.  Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders.

Authors:  Islauddin Khan; Kumari Preeti; Valencia Fernandes; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Cell Mol Neurobiol       Date:  2021-05-01       Impact factor: 4.231

Review 5.  Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review.

Authors:  Ariadna Recasens; Celine Perier; Carolyn M Sue
Journal:  Front Mol Neurosci       Date:  2016-11-21       Impact factor: 5.639

Review 6.  Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System.

Authors:  William T Carrick; Brandi Burks; Murray J Cairns; Jannet Kocerha
Journal:  Front Mol Biosci       Date:  2016-10-25

7.  From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.

Authors:  Sara Redenšek; Vita Dolžan; Tanja Kunej
Journal:  OMICS       Date:  2018-01

Review 8.  MicroRNAs in Parkinson's disease and emerging therapeutic targets.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2017-12       Impact factor: 5.135

Review 9.  microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.

Authors:  Loredana Leggio; Silvia Vivarelli; Francesca L'Episcopo; Cataldo Tirolo; Salvo Caniglia; Nunzio Testa; Bianca Marchetti; Nunzio Iraci
Journal:  Int J Mol Sci       Date:  2017-12-13       Impact factor: 5.923

10.  Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.

Authors:  Kira S Sheinerman; Jon B Toledo; Vladimir G Tsivinsky; David Irwin; Murray Grossman; Daniel Weintraub; Howard I Hurtig; Alice Chen-Plotkin; David A Wolk; Leo F McCluskey; Lauren B Elman; John Q Trojanowski; Samuil R Umansky
Journal:  Alzheimers Res Ther       Date:  2017-11-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.